retatrutide triple agonist obesity trial π¨ HOT OFF THE PRESS: Phase 3 data has arrived β and the medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average retatrutide triple agonist glp-1 gip
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 3 - Aug 8



























